Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masakazu Toi

Showing results (41-50 of 536) with videos related to

Pageof 54
Sort By:
Breast Cancer (Tokyo, Japan)|June 7, 2006
Who benefits from hormone therapy?Masakazu Toi, Yuichi Iino
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 10, 2007
[Herceptin (trastuzumab)]Hiroyasu Yamashiro, Masakazu Toi
Annals of Surgical Oncology|November 3, 2017
Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods for the Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer: A ReplyTomoharu Sugie, Masakazu Toi
Expert Opinion on Pharmacotherapy|March 10, 2018
Abemaciclib for the treatment of breast cancerTakeshi Kotake, Masakazu Toi
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[Molecular targeted therapy and genomic evolution of breast cancer]Fumiaki Sato, Masakazu Toi
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 26, 2003
Anti-angiogenic therapy in breast cancerMohammad Atiqur Rahman, Masakazu Toi
Breast Cancer (Tokyo, Japan)|November 20, 2004
Novel sensitizing agents: potential contribution of COX-2 inhibitor for endocrine therapy of breast cancerShigehira Saji, Makiko Hirose, Masakazu Toi
Medical Oncology (Northwood, London, England)|September 29, 2022
Tumor immune microenvironment and systemic response in breast cancerKosuke Kawaguchi, Yurina Maeshima, Masakazu Toi
Breast Cancer (Tokyo, Japan)|March 5, 2009
Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancerMasakazu Toi, Hiroyasu Yamashiro, Wakako Tsuji
Expert Opinion on Investigational Drugs|April 9, 2010
Combat against cancer with science and medicineLouis W C Chow, Masakazu Toi
Pageof 54

Showing results (41-50 of 536) with videos related to

Sort By:
Pageof 54
Breast Cancer (Tokyo, Japan)|June 7, 2006
Who benefits from hormone therapy?Masakazu Toi, Yuichi Iino
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 10, 2007
[Herceptin (trastuzumab)]Hiroyasu Yamashiro, Masakazu Toi
Annals of Surgical Oncology|November 3, 2017
Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods for the Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer: A ReplyTomoharu Sugie, Masakazu Toi
Expert Opinion on Pharmacotherapy|March 10, 2018
Abemaciclib for the treatment of breast cancerTakeshi Kotake, Masakazu Toi
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 19, 2015
[Molecular targeted therapy and genomic evolution of breast cancer]Fumiaki Sato, Masakazu Toi
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 26, 2003
Anti-angiogenic therapy in breast cancerMohammad Atiqur Rahman, Masakazu Toi
Breast Cancer (Tokyo, Japan)|November 20, 2004
Novel sensitizing agents: potential contribution of COX-2 inhibitor for endocrine therapy of breast cancerShigehira Saji, Makiko Hirose, Masakazu Toi
Medical Oncology (Northwood, London, England)|September 29, 2022
Tumor immune microenvironment and systemic response in breast cancerKosuke Kawaguchi, Yurina Maeshima, Masakazu Toi
Breast Cancer (Tokyo, Japan)|March 5, 2009
Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancerMasakazu Toi, Hiroyasu Yamashiro, Wakako Tsuji
Expert Opinion on Investigational Drugs|April 9, 2010
Combat against cancer with science and medicineLouis W C Chow, Masakazu Toi
Pageof 54